Here’s What the Market Says About Psychedelics

Here’s What the Market Says About Psychedelics

Digital marketing data analysis indicates that prospective patients appear to be curious about emerging psychadelic treatments that are being introduced to the market. The “tripping” and recreational drug use stigma for psychedelics is being acitvely displaced by a...
Ketamine in Canada? It’s On its Way!

Ketamine in Canada? It’s On its Way!

Ketamine Treatment for Depression – Meet the True North Strong and Free From surgical anesthetic to the club drug known as “Special K,” Ketamine has been used for a variety of purposes, some legal, and some not. In the US, the FDA has approved Ketamine for use...
Advertising Intranasal Esketamine (SPRAVATO™)

Advertising Intranasal Esketamine (SPRAVATO™)

When news of the FDA approval of Intranasal Esketamine (SPRAVATO™) hit on March 6th 2019 – it caused a frenzy. An undercurrent of interest had been building for months in what the public hoped was a ‘nose spray’ that could alleviate depression. As...